Akorn, a manufacturer of sterile specialty pharmaceuticals, has announced that its president and CEO, Arthur Przybyl, is leaving the company and that, pending selection of a new president and CEO, a committee of three board members will oversee operations of the company and identify Mr Przybyl's replacement.
Subscribe to our email newsletter
The committee consists of John Kapoor, chairman of the board of directors and directors Randall Wall and Jerry Ellis.
Dr Kapoor said: “Our current management team will execute the strategy for the company to achieve continued growth and success. We will endeavor to identify a replacement as soon as practicable.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.